B Braun
B. Braun Melsungen AG, commonly referred to as B. Braun, is a leading global healthcare company headquartered in Melsungen, Germany. Founded in 1839, B. Braun has established itself as a key player in the medical technology and pharmaceutical sectors, with a strong presence in Europe, Asia, and the Americas. The company specialises in a wide range of products and services, including infusion therapy, pain management, and surgical instruments, all designed to enhance patient safety and improve clinical outcomes. B. Braun is renowned for its commitment to innovation and quality, which has earned it a prominent position in the healthcare market. With a focus on sustainability and a dedication to advancing medical practices, B. Braun continues to achieve significant milestones, reinforcing its reputation as a trusted partner in the healthcare industry.
DitchCarbon Score
How does B Braun's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
B Braun's score of 26 is higher than 51% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
B Braun's reported carbon emissions
In 2024, B. Braun reported total greenhouse gas emissions of approximately 578,300,000 kg CO2e, a slight increase from about 570,600,000 kg CO2e in 2023. This data encompasses Scope 1 and 2 emissions, which are directly associated with the company's operations and energy consumption. Over the past few years, B. Braun has demonstrated a commitment to reducing its carbon footprint, achieving a decrease from about 652,100,000 kg CO2e in 2021 and approximately 614,600,000 kg CO2e in 2022. B. Braun has set an ambitious target to reduce its Scope 1 and 2 greenhouse gas emissions by 50% by 2030, using 2021 as the baseline year. This commitment reflects the company's proactive approach to climate action and aligns with industry standards for sustainability. The reduction initiative is part of B. Braun's broader strategy to enhance environmental performance across its global operations. As of now, there are no reported Scope 3 emissions, which typically include indirect emissions from the supply chain and product use. B. Braun's climate commitments are not cascaded from any parent organization, indicating that these targets and emissions data are independently reported.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|
| Scope 1 | - | - | - | - |
| Scope 2 | - | - | - | - |
| Scope 3 | - | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
B Braun is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
